4
Changes in Ownership
Aclaris Therapeutics, Inc. Filed Acc 0001209191-20-034076
President and CEO gave up 20,976 shares (to pay taxes)
- President and CEO acquired 73,014 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Walker Neal President and CEO | 2020-06-01 | Option exercise | +73,014 | 1,107,907 | D | ||
| Walker Neal President and CEO | 2020-06-01 | Shares withheld for taxes | −20,976 | $1.32 | $27,688 | 1,086,931 | D |
| Derivatives | |||||||
| Walker Neal President and CEO | 2020-06-01 | Option exercise · Restricted stock units | −73,014 | 73,015 | D | ||
Loading xslF345X03/doc4.xml…